https://www.selleckchem.com/products/GDC-0941.html
Venoarterial-extracorporeal membrane oxygenation (VA-ECMO) is currently one of the first-line therapies for refractory cardiogenic shock (CS), but its applicability is undermined by the high morbidity associated with its complications, especially those related to mechanical ventilation (MV). We aimed to assess the prognostic impact of keeping patients in refractory CS awake at cannulation and during the VA-ECMO run. A 7-year database of patients given peripheral VA-ECMO support was used to conduct a propensity-score (PS)-matched analys
Like
Comment
Share
